Estrella Immunopharma Inc...

NASDAQ: ESLA · Real-Time Price · USD
0.90
0.04 (4.60%)
At close: Aug 15, 2025, 2:50 PM

Estrella Immunopharma Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Dec 31, 2022 Jun 30, 2022
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-7.31M -1.57M -1.69M
Interest Income
n/a 654.07K 1.43K
Pretax Income
-7.31M -915.46K -1.69M
Net Income
-7.31M -996.1K -1.69M
Selling & General & Admin
3.2M 1.37M 296.25K
Research & Development
4.11M n/a 1.39M
Other Expenses
n/a -201.31K n/a
Operating Expenses
7.31M 1.57M 1.69M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
7.31M 1.57M 1.69M
Income Tax Expense
1.63K 80.65K -235.14K
Shares Outstanding (Basic)
35.2M 5.76M 5.85M
Shares Outstanding (Diluted)
35.2M 5.76M 5.85M
EPS (Basic)
-0.21 -0.17 -0.29
EPS (Diluted)
-0.21 -0.17 -0.29
EBITDA
-7.31M -915.46K -247.72K
EBIT
-7.31M -915.46K -247.72K
Depreciation & Amortization
n/a 228.49K 236.56K